These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 31890773)
1. Variation in the manufacturing reproducibility of autologous cell-based products depending on raw material shipment conditions. Mizutani M; Terunuma H; Samejima H; Ashiba K; Kino-Oka M Regen Ther; 2019 Dec; 12():102-107. PubMed ID: 31890773 [TBL] [Abstract][Full Text] [Related]
2. Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act. Mizutani M; Samejima H; Terunuma H; Kino-Oka M Regen Ther; 2016 Dec; 5():25-30. PubMed ID: 31245497 [TBL] [Abstract][Full Text] [Related]
4. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 3: Porcine islet product manufacturing and release testing criteria. Rayat GR; Gazda LS; Hawthorne WJ; Hering BJ; Hosking P; Matsumoto S; Rajotte RV Xenotransplantation; 2016; 23(1):38-45. PubMed ID: 26923763 [TBL] [Abstract][Full Text] [Related]
5. Healthcare center-based cell therapy laboratories supporting off-site manufactured cell therapies: The experiences of a single academic cell therapy laboratory. Dinh A; Stroncek DF Transfusion; 2024 Feb; 64(2):357-366. PubMed ID: 38173340 [TBL] [Abstract][Full Text] [Related]
6. Identification of Particles in Parenteral Drug Raw Materials. Lee K; Lankers M; Valet O PDA J Pharm Sci Technol; 2018; 72(6):599-607. PubMed ID: 29669816 [TBL] [Abstract][Full Text] [Related]
7. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing. Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Container Closure System Integrity for Storage of Frozen Drug Products: Impact of Capping Force and Transportation. Nieto A; Roehl H; Adler M; Mohl S PDA J Pharm Sci Technol; 2018; 72(6):544-552. PubMed ID: 29853608 [TBL] [Abstract][Full Text] [Related]
9. Enabling Robust and Rapid Raw Material Identification and Release by Handheld Raman Spectroscopy. Matthews TE; Coffman C; Kolwyck D; Hill D; Dickens JE PDA J Pharm Sci Technol; 2019; 73(4):356-372. PubMed ID: 30770483 [TBL] [Abstract][Full Text] [Related]
10. Parallel-batch scheduling and transportation coordination with waiting time constraint. Gong H; Chen D; Xu K ScientificWorldJournal; 2014; 2014():356364. PubMed ID: 24883385 [TBL] [Abstract][Full Text] [Related]
12. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon. Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945 [TBL] [Abstract][Full Text] [Related]
13. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing. Korbutt GS Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762 [TBL] [Abstract][Full Text] [Related]
14. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal. Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502 [TBL] [Abstract][Full Text] [Related]
15. Near infrared spectroscopy based monitoring of extraction processes of raw material with the help of dynamic predictive modeling. Wang H; Suo T; Wu X; Zhang Y; Wang C; Yu H; Li Z Spectrochim Acta A Mol Biomol Spectrosc; 2018 Mar; 192():222-227. PubMed ID: 29149693 [TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing. Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281 [TBL] [Abstract][Full Text] [Related]
17. Approach of resource expenditure estimation toward mechanization in the manufacturing of cell-based products. Mizutani M; Nakajima K; Kino-Oka M Regen Ther; 2022 Jun; 20():9-17. PubMed ID: 35350420 [TBL] [Abstract][Full Text] [Related]
18. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data. Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359 [TBL] [Abstract][Full Text] [Related]
19. Influence of raw milk quality on processed dairy products: How do raw milk quality test results relate to product quality and yield? Murphy SC; Martin NH; Barbano DM; Wiedmann M J Dairy Sci; 2016 Dec; 99(12):10128-10149. PubMed ID: 27665134 [TBL] [Abstract][Full Text] [Related]
20. How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing? Chen LN; Collins-Johnson N; Sapp N; Pickett A; West K; Stroncek DF; Panch SR Transfusion; 2019 Aug; 59(8):2506-2518. PubMed ID: 31135995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]